Rifabutin
Mycobutin (rifabutin) is a small molecule pharmaceutical. Rifabutin was first approved as Mycobutin on 1992-12-23. It is used to treat mycobacterium avium-intracellulare infection, mycobacterium infections, and pulmonary tuberculosis in the USA.
| Trade Name | Mycobutin |
|---|---|
| Common Name | Rifabutin |
| Indication | mycobacterium avium-intracellulare infection, mycobacterium infections, pulmonary tuberculosis |
| Drug Class | Antibiotics (rifamycin derivatives) |
